Copyright Reports & Markets. All rights reserved.

Global Cardiac Biomarkers Testing Device Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cardiac Biomarkers Testing Device Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Instrument
    • 1.3.3 Reagent
    • 1.3.4 Reagent Test Kit
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cardiac Biomarkers Testing Device Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Pathology Laboratory
    • 1.4.4 Others
  • 1.5 Global Cardiac Biomarkers Testing Device Market Size & Forecast
    • 1.5.1 Global Cardiac Biomarkers Testing Device Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Cardiac Biomarkers Testing Device Sales Quantity (2020-2031)
    • 1.5.3 Global Cardiac Biomarkers Testing Device Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Cardiac Biomarkers Testing Device Product and Services
    • 2.1.4 Abbott Laboratories Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Abbott Laboratories Recent Developments/Updates
  • 2.2 Beckman Coulter
    • 2.2.1 Beckman Coulter Details
    • 2.2.2 Beckman Coulter Major Business
    • 2.2.3 Beckman Coulter Cardiac Biomarkers Testing Device Product and Services
    • 2.2.4 Beckman Coulter Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Beckman Coulter Recent Developments/Updates
  • 2.3 Bio-Rad Laboratories
    • 2.3.1 Bio-Rad Laboratories Details
    • 2.3.2 Bio-Rad Laboratories Major Business
    • 2.3.3 Bio-Rad Laboratories Cardiac Biomarkers Testing Device Product and Services
    • 2.3.4 Bio-Rad Laboratories Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Bio-Rad Laboratories Recent Developments/Updates
  • 2.4 CardioGenics Holdings
    • 2.4.1 CardioGenics Holdings Details
    • 2.4.2 CardioGenics Holdings Major Business
    • 2.4.3 CardioGenics Holdings Cardiac Biomarkers Testing Device Product and Services
    • 2.4.4 CardioGenics Holdings Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 CardioGenics Holdings Recent Developments/Updates
  • 2.5 Cortez Diagnostics
    • 2.5.1 Cortez Diagnostics Details
    • 2.5.2 Cortez Diagnostics Major Business
    • 2.5.3 Cortez Diagnostics Cardiac Biomarkers Testing Device Product and Services
    • 2.5.4 Cortez Diagnostics Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Cortez Diagnostics Recent Developments/Updates
  • 2.6 DIALAB GmbH
    • 2.6.1 DIALAB GmbH Details
    • 2.6.2 DIALAB GmbH Major Business
    • 2.6.3 DIALAB GmbH Cardiac Biomarkers Testing Device Product and Services
    • 2.6.4 DIALAB GmbH Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 DIALAB GmbH Recent Developments/Updates
  • 2.7 Eurolyser Diagnostica GmbH
    • 2.7.1 Eurolyser Diagnostica GmbH Details
    • 2.7.2 Eurolyser Diagnostica GmbH Major Business
    • 2.7.3 Eurolyser Diagnostica GmbH Cardiac Biomarkers Testing Device Product and Services
    • 2.7.4 Eurolyser Diagnostica GmbH Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Eurolyser Diagnostica GmbH Recent Developments/Updates
  • 2.8 F. Hoffmann-La Roche AG
    • 2.8.1 F. Hoffmann-La Roche AG Details
    • 2.8.2 F. Hoffmann-La Roche AG Major Business
    • 2.8.3 F. Hoffmann-La Roche AG Cardiac Biomarkers Testing Device Product and Services
    • 2.8.4 F. Hoffmann-La Roche AG Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 F. Hoffmann-La Roche AG Recent Developments/Updates
  • 2.9 Randox Laboratories
    • 2.9.1 Randox Laboratories Details
    • 2.9.2 Randox Laboratories Major Business
    • 2.9.3 Randox Laboratories Cardiac Biomarkers Testing Device Product and Services
    • 2.9.4 Randox Laboratories Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Randox Laboratories Recent Developments/Updates
  • 2.10 Siemens Healthcare GmbH
    • 2.10.1 Siemens Healthcare GmbH Details
    • 2.10.2 Siemens Healthcare GmbH Major Business
    • 2.10.3 Siemens Healthcare GmbH Cardiac Biomarkers Testing Device Product and Services
    • 2.10.4 Siemens Healthcare GmbH Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Siemens Healthcare GmbH Recent Developments/Updates
  • 2.11 Thermo Fischer Scientific
    • 2.11.1 Thermo Fischer Scientific Details
    • 2.11.2 Thermo Fischer Scientific Major Business
    • 2.11.3 Thermo Fischer Scientific Cardiac Biomarkers Testing Device Product and Services
    • 2.11.4 Thermo Fischer Scientific Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Thermo Fischer Scientific Recent Developments/Updates
  • 2.12 Tosoh Corporation
    • 2.12.1 Tosoh Corporation Details
    • 2.12.2 Tosoh Corporation Major Business
    • 2.12.3 Tosoh Corporation Cardiac Biomarkers Testing Device Product and Services
    • 2.12.4 Tosoh Corporation Cardiac Biomarkers Testing Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Tosoh Corporation Recent Developments/Updates

3 Competitive Environment: Cardiac Biomarkers Testing Device by Manufacturer

  • 3.1 Global Cardiac Biomarkers Testing Device Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Cardiac Biomarkers Testing Device Revenue by Manufacturer (2020-2025)
  • 3.3 Global Cardiac Biomarkers Testing Device Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Cardiac Biomarkers Testing Device by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Cardiac Biomarkers Testing Device Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Cardiac Biomarkers Testing Device Manufacturer Market Share in 2024
  • 3.5 Cardiac Biomarkers Testing Device Market: Overall Company Footprint Analysis
    • 3.5.1 Cardiac Biomarkers Testing Device Market: Region Footprint
    • 3.5.2 Cardiac Biomarkers Testing Device Market: Company Product Type Footprint
    • 3.5.3 Cardiac Biomarkers Testing Device Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cardiac Biomarkers Testing Device Market Size by Region
    • 4.1.1 Global Cardiac Biomarkers Testing Device Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Cardiac Biomarkers Testing Device Consumption Value by Region (2020-2031)
    • 4.1.3 Global Cardiac Biomarkers Testing Device Average Price by Region (2020-2031)
  • 4.2 North America Cardiac Biomarkers Testing Device Consumption Value (2020-2031)
  • 4.3 Europe Cardiac Biomarkers Testing Device Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Cardiac Biomarkers Testing Device Consumption Value (2020-2031)
  • 4.5 South America Cardiac Biomarkers Testing Device Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Cardiac Biomarkers Testing Device Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Cardiac Biomarkers Testing Device Sales Quantity by Type (2020-2031)
  • 5.2 Global Cardiac Biomarkers Testing Device Consumption Value by Type (2020-2031)
  • 5.3 Global Cardiac Biomarkers Testing Device Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Cardiac Biomarkers Testing Device Sales Quantity by Application (2020-2031)
  • 6.2 Global Cardiac Biomarkers Testing Device Consumption Value by Application (2020-2031)
  • 6.3 Global Cardiac Biomarkers Testing Device Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Cardiac Biomarkers Testing Device Sales Quantity by Type (2020-2031)
  • 7.2 North America Cardiac Biomarkers Testing Device Sales Quantity by Application (2020-2031)
  • 7.3 North America Cardiac Biomarkers Testing Device Market Size by Country
    • 7.3.1 North America Cardiac Biomarkers Testing Device Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Cardiac Biomarkers Testing Device Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Cardiac Biomarkers Testing Device Sales Quantity by Type (2020-2031)
  • 8.2 Europe Cardiac Biomarkers Testing Device Sales Quantity by Application (2020-2031)
  • 8.3 Europe Cardiac Biomarkers Testing Device Market Size by Country
    • 8.3.1 Europe Cardiac Biomarkers Testing Device Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Cardiac Biomarkers Testing Device Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cardiac Biomarkers Testing Device Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Cardiac Biomarkers Testing Device Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Cardiac Biomarkers Testing Device Market Size by Region
    • 9.3.1 Asia-Pacific Cardiac Biomarkers Testing Device Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Cardiac Biomarkers Testing Device Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Cardiac Biomarkers Testing Device Sales Quantity by Type (2020-2031)
  • 10.2 South America Cardiac Biomarkers Testing Device Sales Quantity by Application (2020-2031)
  • 10.3 South America Cardiac Biomarkers Testing Device Market Size by Country
    • 10.3.1 South America Cardiac Biomarkers Testing Device Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Cardiac Biomarkers Testing Device Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cardiac Biomarkers Testing Device Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Cardiac Biomarkers Testing Device Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Cardiac Biomarkers Testing Device Market Size by Country
    • 11.3.1 Middle East & Africa Cardiac Biomarkers Testing Device Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Cardiac Biomarkers Testing Device Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Cardiac Biomarkers Testing Device Market Drivers
  • 12.2 Cardiac Biomarkers Testing Device Market Restraints
  • 12.3 Cardiac Biomarkers Testing Device Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cardiac Biomarkers Testing Device and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cardiac Biomarkers Testing Device
  • 13.3 Cardiac Biomarkers Testing Device Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cardiac Biomarkers Testing Device Typical Distributors
  • 14.3 Cardiac Biomarkers Testing Device Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cardiac Biomarkers Testing Device market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Cardiac Biomarkers Testing Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Cardiac Biomarkers Testing Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Cardiac Biomarkers Testing Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Cardiac Biomarkers Testing Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Cardiac Biomarkers Testing Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cardiac Biomarkers Testing Device
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cardiac Biomarkers Testing Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, CardioGenics Holdings, Cortez Diagnostics, DIALAB GmbH, Eurolyser Diagnostica GmbH, F. Hoffmann-La Roche AG, Randox Laboratories, Siemens Healthcare GmbH, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Cardiac Biomarkers Testing Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Instrument
    Reagent
    Reagent Test Kit
    Market segment by Application
    Hospital
    Pathology Laboratory
    Others
    Major players covered
    Abbott Laboratories
    Beckman Coulter
    Bio-Rad Laboratories
    CardioGenics Holdings
    Cortez Diagnostics
    DIALAB GmbH
    Eurolyser Diagnostica GmbH
    F. Hoffmann-La Roche AG
    Randox Laboratories
    Siemens Healthcare GmbH
    Thermo Fischer Scientific
    Tosoh Corporation
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cardiac Biomarkers Testing Device product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cardiac Biomarkers Testing Device, with price, sales quantity, revenue, and global market share of Cardiac Biomarkers Testing Device from 2020 to 2025.
    Chapter 3, the Cardiac Biomarkers Testing Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cardiac Biomarkers Testing Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cardiac Biomarkers Testing Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiac Biomarkers Testing Device.
    Chapter 14 and 15, to describe Cardiac Biomarkers Testing Device sales channel, distributors, customers, research findings and conclusion.

    Buy now